Loading, please wait ...


News Analytics

ed7c1621 5a59 45ec bd6e 877229c0f584?size=1.
Clinical-stage monoclonal antibody in development for rare genetic bone disease that builds on Ultragenyx’s existing bone franchise Ultragenyx leads and funds development to approval; Mereo retains commercial rights in Europe, Ultragenyx commercializes in US and in rest of world Mereo receives $50 million upfront and is eligible for milestones up to $254 million NOVATO, Calif., LONDON, and REDWOOD CITY, Calif., Dec. 17, 2020 (...
Google

Subject Matter

  • Science and technology 47.37%
  • Healthcare 27.63%
    • Hospitals, doctors and medical care 100.00%
  • Business, economics, society 25.00%
    • Companies, industries, organizations 100.00%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions